Hangzhou AllTest Biotech Co., Ltd
Simplifying Drugs of Abuse Testing for Workplaces

Drug abuse testing is conducted for medical purposes and legal causes, such as in workplaces, mandated by a court-order, or when ordered by a health practitioner to monitor known or suspected substances. Organizations may perform testing to detect illicit drug use or monitor medication compliance. Recent growth in pain management and opioid dependency clinics has dramatically increased the demand for urine drug testing. As urine drug screening is used for many different purposes and patient populations, using more compatible products that can meet the vast majority of drug screening procedures is essential for testing organizations. These organizations also need to optimize their products to achieve higher accuracy, improve sensitivity, and detect any drugs of abuse, even in the lowest concentration.



Hangzhou AllTest Biotech is blazing a trail and helping businesses screen their potential employees for drug and other illicit substance addiction is. AllTest’s drugs of abuse rapid testing reagents can detect nearly 70 types of drugs and substances, covering most of the world’s drug types. “We have a wide range of drugs of abuse rapid test products compatible with Food and Drug Administration (FDA) and European health, safety, and environmental protection standards,” notes Gao Fei, chairman of AllTest. The company offers these drugs of abuse rapid test kits throughout the Asia-Pacific region and other global regions to help businesses and organizations create a motivated and healthy workforce.

Alltest’s Rich Industry Experience

AllTest has built a solid foundation in in-vitro diagnostics which stems from the company’s top-notch industry professionals who have proven expertise in innovation management, be it a product or industry transforming process developments. AllTest’s R&D team’s main product researchers have more than ten years of experience in product design and development.

Additionally, AllTest’s management team emphasizes innovation and investment in research and development. These capabilities allow AllTest to develop new types of products in order to keep pace with the global in-vitro diagnostics industry. Moreover, the company focuses strongly on its research and technology team and has established a mechanism for encouraging innovation. AllTest follows this principle from the beginning of the recruitment process to the training of employees and then to the development prospects of our employees. This focus on encouraging innovation ensures that all AllTest employees have a keen sense of the market and rapid research and development capabilities.

Alltest’s Illustrated Drug Screening Solutions

A testament to the benefits of AllTest’s extensive in-house R&D capabilities is its multi-drug combination test kit (9-in-1), which is essentially the first of its kind in the Chinese market. In addition, AllTest offers various types of drug screening tools and the most popular among them is AllTest’s FKET (F-Ketamine) Rapid Test kit. F-Ketamine is generally used as the replacement of ketamine with hallucinogenic properties. When abused, users develop distorted perceptions of sight and sound and feel out of control.The research on the regulation of F-Ketamine is currently minimal.



Therefore, a large number of people abuse F-Ketamine instead of ketamine. Currently, the detection of F-Ketamine is limited to high performance liquid chromatography (HPLC), gas chromatograph-mass spectrometer (GC-MS), and thin-layer chromatography (TLC), which require not only expensive equipment but professional analysis. At the same time, high purity of test materials and complex operation are necessary. Against this backdrop, FKET products are a new type of drug detection reagents developed independently by AllTest, including developing antigens and antibodies and optimizing product buffer systems which deliver unmatched product sensitivity and specificity. At its core, FKET is a rapid urine screening test that can be performed without using an instrument. The test utilizes a monoclonal antibody to detect elevated levels of F-Ketamine in urine selectively. The test yields a positive result when F-Ketamine in urine exceeds 1000ng/ml.

We Have A Wide Range Of Drugs Of Abuse Rapid Test Products Compatible With Food And Drug Administration (FDA) And European Health, Safety, And Environmental Protection Standards

AllTest’s product portfolio, nevertheless, doesn’t end just there. The company also offers Multi-Drug Rapid Test Device which is suitable for testing oral fluid specimens. The Multi-Drug Rapid Test is a rapid screening test that can be performed without using an instrument. The test utilizes monoclonal antibodies to detect elevated levels of specific drugs in the specimen selectively. It is a rapid test for the simultaneous, qualitative detection of multiple drugs and drug metabolites in the human specimen. Alongside this, AllTest also offers a Multi-Drug Rapid Test Cassette, a rapid screening test that can be performed without using an instrument.

Alltest’s Other Ivd Capabilities

The capabilities of AllTest, however, stretch well beyond just the IVD drug testing kits. The company also offers various IVD tests for tumors, cardiac complications, and other infectious disease screening, including COVID-19 disease.

The recent addition to this suite of tests is the Dust Mite IgE Rapid Test kit. Dust mite allergy is an IgE mediated type 1 hypersensitivity reaction to dust mite allergens, commonly found in household dust. The Dust Mite IgE Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection of human IgE antibody to dust mite in venipuncture whole blood, serum, or plasma to aid in diagnosing the allergy. In addition, AllTest offers IVD solutions for diagnosing different veterinary diseases among dogs, cats, pigs, and cows. This makes AllTest a genuine all-rounder in the IVD space.

Proven Success

The innovative nature of AllTest can be best explained through a recent case study. One of AllTest’s customers requested a Multi-Drug panel that could detect 20 drugs at one time. The AllTest R&D team quickly developed the 20-in-1 panel with independent intellectual property rights, which can detect at least 20 drugs simultaneously with only one sample, significantly improving the speed of drug screening and meeting the customer’s demand for efficient and rapid drugs of abuse detection.

As the customer was unfamiliar with the operating procedures of the reagents, AllTest arranged a training session on drug testing reagents and resolved the customer’s issue through online and offline support. AllTest partnered with the customer to develop more convenient screening operations through an interpersonal approach, top-notch product quality and customer service.

Moving ahead with many similar customer success stories under its belt, AllTest is now poised to grow its product portfolio even more in the coming months and years ahead. These initiatives go on to support AllTest’s vision of emerging as one of the most innovative and reliable providers of IVD products at affordable prices and consistency in quality. With more than 100 customers in Europe, Asia, Africa, North America, South America, and Oceania, AllTest will continue innovating and developing new products to support more customers worldwide.